Simultaneous Systematic Approach to Enable Predictive, Preventive and Personalized Medicine – Women Healthcare as a Case Study

Advances in Predictive, Preventive and Personalised Medicine

Volumn 1, Issue , 2012, Pages 313-331

  Marcus Kalish, Mira ^a   Meiri, Hamutal ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TeleMarpeh Ltd   (Israel)

Author keywords

Converging Humanities; Education; Information Communication Technology; Matrix analysis approach; Personalized medicine; Science and Technology (CHEST); Simultaneous Systematic Analysis; Women health

Indexed keywords

EID: 84927744345     PISSN: 22113495     EISSN: 22113509     Source Type: Book Series    
DOI: 10.1007/978-94-007-4602-2_17     Document Type: Chapter

References (54)

1. Zhong XY, Wang Y, Chen S, Pubuzhuoma L, Ouzhuwangmu G, Hahn C, Holzgreve W, Hahn S (2004) Circulating fetal DNA in maternal plasma is increased in pregnancies at high altitude and is further enhanced by preeclampsia. Clin Chem 50:2403–2405
2. Zamudio S, Postigo L, Illsley NP, Rodriguez C, Heredia G, Brimacombe M, Echalar L, Torricos T, Tellez W, Maldonado I, Balanza E, Alvarez T, Ameller J, Vargas E (2007) Maternal oxygen delivery is not related to altitude-and ancestry-associated differences in human fetal growth. J Physiol 582(2):883–895
3. Ye J, Cheng X, Chen X, Ye F, Lü W, Xie X (2010) Prevalence and risk profile of cervical human papilloma virus infection in Zhejiang Province, southeast China: a population-based study. Virol J 7:66. doi:10.1186/1743-422X-7-66
4. Maucort-Boulch D, Franceschi S, Plummer M, the IARC HPV (2008) International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 17:717–720
5. Sundin J, Willner S (2008) The history of social determinants and health in Europe. A Swedish example. In: Hardy A, Cook HJ, McKenna ND, Bhattacharya S (eds) History of social determinants of health global histories, contemporary debated. Orient Longman India Ltd./Sangam Books, New Delhi/London, Chapter 4, 207 pp
6. Felder S (2006) The gender longevity gap: explaining the difference between singles and couples. J popul Econ 19:543–547
7. Rastogi T, Devesa S, Mangtani P, Mathew A, Cooper N, Kao R, Sinha R (2008) Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol 37:147–160
8. Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC (2009) Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr 89:1145–1154
9. Semelweis IP (1858) A gyermekágyi láz kóroktana. Orvosi hetilap 2(1858) (translated into German by Tiberius von Györy’s, Semmelweis’s gesammelte Werke, Gustav Fischer, Jena, 1905), 61–83. (This was Semmelweis’s first publication on the subject of puerperal fever. According to Győry the substance of the report was contained in lectures delivered before the Budapester Königliche Ârzteverein in the spring of 1858)
10. Gottvall T, Hildén JO, Nelson N, Filbey D (1995) Severe Rh(D) immunization: anti-D quantitation and treatment possibilities during pregnancy and after birth. Acta Paediatr 84(11):1315–1317
11. Bombard AT, Akolekar R, Farkas DH, Vanagtmael AL, Aquino F, Oeth P, Nicolaides KH (2011) Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 31:802–808
12. Fauser BC, Diedrich K, Bouchard P, Dominguez F, Matzuk M, Franks S, Hamamah S, Simon C, Devroey P, Ezcurra D, Howles CM (2011) Contemporary genetic technologies and female reproduction. Hum Reprod Update 17:829–847
13. Sagi M, Weinberg N, Eilat A, Aizenman E, Werner M, Girsh E, Siminovsky Y, Abeliovich D, Peretz T, Simon A, Laufer N (2009) Preimplantation genetic diagnosis for BRCA1/2–a novel clinical experience. Prenat Diagn 29:508–513
14. Menon U, Harper J, Sharma A, Fraser L, Burnell M, ElMasry K, Rodeck C, Jacobs I (2007) Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 22:1573–1577
15. Eid J, Fehr A, Gray J, Luong J, Otto G, Peluso P, Rank D, Baybayan P, Bettman B, Bibillo A, Bjornson K, Chaudhuri B, Christians F, Cicero R, Clark S, Dalal R, Dewinter A, Dixon J, Foquet M, Gaertner A, Hardenbol P, Heiner C, Hester K, Holden D, Kearns G, Kong X, Kuse R, Lacroix Y, Lin S, Lundquist P, Ma C, Marks P, Maxham M, Murphy D, Park I, Pham T, Phillips M, Roy J, Sebra R, Shen G, Sorenson J, Tomaney A, Travers K, Trulson M, Vieceli J, Wegener J, Wu D, Yang A, Zaccarin D, Zhao P, Zhong F, Korlach J, Turner S (2009) Real-time DNA sequencing from single polymerase molecules. Science 323:133–138
16. Bandura DR, Baranov VI, Ornatsky O, Antonov A, Kinach R, Lou X, Pavlov S, Vorobiev S, Dick JE, Tanner SD (2009) Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 81:6813–6822
17. Kale MS, Bishop TF, Federman AD, Keyhani S (2011) “Top 5” lists top $5 billion. Arch Intern Med 171:1856–1858
18. Lesko LJ (2007) Personalized medicine: elusive dream or imminent reality? Clinical Pharmacol Therapeut 81:807–816
19. Stargardt T (2011) The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany. Eur J Health Econ 11:267–277
20. Gurwitz D, Lunshof JE (2009) Personalized pharmacotherapy: genotypes, biomarkers, and beyond. Clin Pharmacol Ther 85:142
21. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308:1583–1587
22. Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290–e296
23. Metzger BE (2007) Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50:972–979
24. Silander K, Alanne M, Kristiansson K, Saarela O, Ripatti S, Auro K, Karvanen J, Kulathinal S, Niemelä M, Ellonen P, Vartiainen E, Jousilahti P, Saarela J, Kuulasmaa K, Evans A, Perola M, Salomaa V, Peltonen L (2011) Gender differences in genetic risk profiles for cardiovascular disease. PLoS One 3(10):e3601–e3615
25. Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEAR T study): case– control study. Lancet 364:937–952
26. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ (2008) Cardiovascular sequleae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 156:918–930
27. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599–2610
28. Slamon DJ, Godolphin W, Jones LA et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712
29. Wu F, Hu CH, Jiang SA, Lu FG, Lin MH, Deng XG (2007) Herceptin plus adjuvant chemotherapy for the prognosis of patients with human epithelial growth factor receptor 2 positive early-stage breast cancer: a meta-analysis]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32:684–689
30. Di Cosmino S, Baselga J (2010) Management of breast cancer with targeted agents: importance of heterogenicity. Nat Rev Clin Oncol 7:139–147
31. Regan M for the members of the BIG 1–98 Collaborative Group and the International Breast Cancer Study Group (IBCSG) (2011) Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1–98 randomised clinical trial at 81 years median follow-up. Lancet Oncol 12: 1101–1108
32. Tageja N (2010) Is it safe to use transtuzumab for the treatment of breast cancer during pregnancy. Cancer symposium Part III, S292
33. Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, Wierda WG, Keating MJ, Luthra R (2009) Customized oligo nucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia. J Mol Diagn 11: 25–34
34. Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE (2006) Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med 145(6):435–447
35. Shapira T, Pereg D, Lishner M (2008) How I treat acute and chronic leukemia in pregnancy. Blood Rev 22(5):247–259
36. Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, Burton EA, Wong B, Tsang G, West BL, Powell B, Shellooe R, Marimuthu A, Nguyen H, Zhang KY, Artis DR, Schlessinger J, Su F, Higgins B, Iyer R, D’Andrea K, Koehler A, Stumm M, Lin PS, Lee RJ, Grippo J, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, Chapman PB, Flaherty KT, Xu X, Nathanson KL, Nolop K (2010) Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467(7315):596–599
37. Johnston S, Pippen J Jr, Pivot X, Lichinitser M, Sadeghi S, Dieras V, Gomez HL, Romieu G, Manikhas A, Kennedy MJ, Press MF, Maltzman J, Florance A, O’Rourke L, Oliva C, Stein S, Pegram M (2009) Lapatinib combined with letrozole vs letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer. J Clin Oncol 27:5538–5546
38. Kagan K, Staboulidou I, Cruz JJ, Wright D, Nicolaides K (2010) Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol 36:542–547
39. Sahota DS, Kagan KO, Lau TK, Leung TY, Nicolaides KH (2008) Customized birth weight: coefficients and validation of models in a UK population. Ultrasound Obstet Gynecol 32: 884–889
40. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH (2011) Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn 31:58–65
41. Baschat AA (2010) Fetal growth restriction-from observation to intervention. J Perinat Med 38:239–246
42. Beltrand J, Verkauskiene R, Nicolescu R, Sibony O, Gaucherand P, Chevenne D, Claris O, Lévy-Marchal C (2008) Adaptive changes in neonatal hormonal and metabolic profiles induced by fetal growth restriction. J Clin Endocrinol Metab 93:4027–4032
43. Wright D, Syngelaki A, Staboulidou I, Cruz JJ, Nicolaides KH (2011) Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn 31:16–21
44. Brodszki J, Länne T, Maršál K, Ley D (2005) Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation 111:2623–2628
45. Bronwen GB, Lois J (2004) Pregnancy in adolescents with type 1 diabetes. Growth Genet Horm J 20:20–24
46. Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, Mandia L, Nicolaides K, Redman C, Soothill P, Spencer K, Thilaganathan B, Williams D, Meiri H (2011) Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 32(Supplement 1):S4–S16
47. Dekker G, Robillard PY, Roberts C (2011) The etiology of preeclampsia: the role of the father. Int J Gynecol Obstet 50:17–19
48. Redman CW, Sargent IL (2009) Placental stress and preeclampsia: a revised view. Placenta 30:S38–S42
49. Roco M (2011) The long view of nanotechnology development-the NNI at 10 years.break J Nanopart Res 13:427–445
50. Blom I (2005) The establishment of maternal clinic’s in Norway – infant mortality and marital fertility. In: The proceeding of gender and developmental perspectives on infant mortality decline, University of Tromsø, pp 1–15
51. WizWhy Ltd. (2003) System and method for revealing necessary and sufficient conditions for database analysis. US Patent 6,542,881
52. Rutkowski L, Scherer R, Tadeusiewicz R, Zadeh LA, Zurada JM (eds) (2010) ICAISC 2010, Part I, LNAI 6113. Springer, Berlin/Heidelberg
53. Sharp PA, Langer R (2011) Promoting convergence in biomedical science. Science 333: 527–529
54. “Convergence” Signals a New Frontier—and Departure from Tradition—in Biomedicine. http://www.aaas.org/news/releases/2011/0118convergence.shtml. Accessed20 June 2012